Effect of different doses of galcanezumab vs placebo for episodic migraine prevention: a randomized clinical trial

V Skljarevski, TM Oakes, QI Zhang… - JAMA …, 2018 - jamanetwork.com
Importance Galcanezumab (LY2951742), a monoclonal antibody against calcitonin gene-
related peptide (CGRP), is one of a novel class of new medicines for migraine prevention …
被引用次数：195 相关文章

Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention: A Randomized Clinical Trial.

V Skljarevski, TM Oakes, Q Zhang… - JAMA …, 2018 - search.ebscohost.com
Abstract IMPORTANCE: Galcanezumab (LY2951742), a monoclonal antibody against
calcitonin gene-related peptide (CGRP), is one of a novel class of new medicines for …

Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention: A Randomized Clinical Trial.

V Skljarevski, TM Oakes, Q Zhang, MB Ferguson… - JAMA …, 2018 - europepmc.org
Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention: A
Randomized Clinical Trial. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

Effect of different doses of Galcanezumab vs Placebo for episodic migraine prevention a randomized clinical trial

V Skljarevski, TM Oakes, Q Zhang… - JAMA …, 2018 - mayoclinic.elsevierpure.com
Abstract IMPORTANCE Galcanezumab (LY2951742), a monoclonal antibody against
calcitonin gene-related peptide (CGRP), is one of a novel class of new medicines for …

Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention: A Randomized Clinical Trial

V Skljarevski, TM Oakes, Q Zhang… - JAMA …, 2018 - pubmed.ncbi.nlm.nih.gov
Importance Galcanezumab (LY2951742), a monoclonal antibody against calcitonin gene-
related peptide (CGRP), is one of a novel class of new medicines for migraine prevention …
[HTML] nih.gov

[HTML][HTML] Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention: A Randomized Clinical Trial

V Skljarevski, TM Oakes, Q Zhang, MB Ferguson… - JAMA …, 2018 - ncbi.nlm.nih.gov
Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention -
PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …
[PDF] researchgate.net

[PDF][PDF] Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention A Randomized Clinical Trial

J Martinez, A Camporeale, KW Johnson, Q Shan… - 2017 - researchgate.net
OBJECTIVE To assess whether at least 1 dose of galcanezumab was superior to placebo for
episodic migraine prevention. DESIGN, SETTING, AND PARTICIPANTS A randomized …

Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention: A Randomized Clinical Trial.

V Skljarevski, TM Oakes, Q Zhang, MB Ferguson… - JAMA …, 2018 - europepmc.org
Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention: A
Randomized Clinical Trial. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …